Evidence map›Paper›PMID 30103044›Full record

ReviewAutoimmunity reviews2018

Recommendations and barriers to vaccination in systemic lupus erythematosus.

Megha Garg, Naaima Mufti, Tara N Palmore, Sarfaraz A Hasni

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Autoimmunity reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Autoimmunity in 2018.Clinical reviews in allergy & immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Megha GargTranslational Autoinflammatory Disease Studies, NIAID, NIH, Bethesda, MD, USA; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA.
Naaima MuftiWomen Medical College, Pakistan.
Tara N PalmoreNational Institutes of Health Clinical Center, Bethesda, MD, USA.
Sarfaraz A HasniNational Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA. Electronic address: sarfaraz.hasni@nih.gov.

Funding

Intramural NIH HHS Z99 AR999999
6 · The paper itself

Abstract

Patients with Systemic Lupus Erythematosus (SLE) pose a unique dilemma pertaining to immunization against common pathogens. SLE patients are usually not immunized with vaccines based on the fear of either precipitating infection in this immunosuppressed patient population (with live vaccines) or aggravating autoimmunity and hence lupus flares (with any vaccines). However, elevated vulnerability to infection makes patients with SLE precisely the population that needs protection from vaccine-preventable diseases. A summary of guidelines from the Centers for Disease Control and Prevention, professional societies, review articles and expert opinions regarding use of individual vaccines applicable to adults with SLE is presented in this review.

Indexed as

Adjuvants, ImmunologicAdultClinical Studies as TopicHumansImmunocompromised HostLupus Erythematosus, SystemicPractice Guidelines as TopicVaccinationVaccinesVaccines, InactivatedAdjuvants, ImmunologicVaccinesVaccines, InactivatedLupusVaccination

Identifiers

PMID30103044
PMCPMC6150817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.